ASX - By Stock
|
SLX |
Re:
30th June 2022 Share Price Prediction
|
|
PVPVG
|
92 |
34K |
2 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
92
|
34K
|
2
|
|
ASX - By Stock
|
SLX Energy |
Re:
Nuclear Power Related Media Thread
|
|
PVPVG
|
5.0K |
2.1M |
5 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
5.0K
|
2.1M
|
5
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
PVPVG
|
4.5K |
1.2M |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
4.5K
|
1.2M
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Drug development webinar presentation
|
|
PVPVG
|
9 |
3.1K |
7 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
9
|
3.1K
|
7
|
|
ASX - By Stock
|
ADO Technology |
Re:
What is the relevance of Anteo’s battery data?
|
|
PVPVG
|
500 |
388K |
5 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
500
|
388K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
PVPVG
|
94 |
27K |
11 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
94
|
27K
|
11
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
PVPVG
|
2.6K |
803K |
37 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
2.6K
|
803K
|
37
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
PVPVG
|
94 |
27K |
5 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
PVPVG
|
94 |
27K |
11 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
11
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
PVPVG
|
17 |
5.7K |
6 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
17
|
5.7K
|
6
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Trading halt
|
|
PVPVG
|
49 |
18K |
1 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
49
|
18K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Updated COVID-19 RAT receives Regulatory Approval in Europe
|
|
PVPVG
|
134 |
60K |
34 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
134
|
60K
|
34
|
|
ASX - By Stock
|
SLX |
Re:
Chart for those interested 2021
|
|
PVPVG
|
282 |
81K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
282
|
81K
|
2
|
|
ASX - By Stock
|
SLX |
Re:
Chart for those interested 2021
|
|
PVPVG
|
282 |
81K |
4 |
15/05/22 |
15/05/22 |
ASX - By Stock
|
282
|
81K
|
4
|
|
ASX - By Stock
|
RNT Technology |
Re:
Chart Thread
|
|
PVPVG
|
211 |
139K |
2 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
211
|
139K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
PVPVG
|
31 |
7.9K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
31
|
7.9K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
|
|
PVPVG
|
43 |
10K |
10 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
43
|
10K
|
10
|
|
ASX - By Stock
|
SLX |
Re:
Chart for those interested 2021
|
|
PVPVG
|
282 |
81K |
3 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
282
|
81K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
|
|
PVPVG
|
43 |
10K |
14 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
43
|
10K
|
14
|
|
ASX - By Stock
|
RNT |
Re:
Ann: Quarterly Report and Appendix 4C
|
|
PVPVG
|
20 |
9.6K |
8 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
20
|
9.6K
|
8
|
|
ASX - By Stock
|
RNT Technology |
Re:
Chart Thread
|
|
PVPVG
|
211 |
139K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
211
|
139K
|
0
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
PVPVG
|
4.5K |
1.2M |
14 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
4.5K
|
1.2M
|
14
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
|
|
PVPVG
|
43 |
10K |
2 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
43
|
10K
|
2
|
|
ASX - By Stock
|
RNT |
Re:
Ann: Half Year Results - Invitation to Webinar
|
|
PVPVG
|
51 |
20K |
0 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
51
|
20K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
PVPVG
|
2.6K |
803K |
7 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
2.6K
|
803K
|
7
|
|
ASX - By Stock
|
ADO |
Re:
Ellume?
|
|
PVPVG
|
170 |
61K |
14 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
170
|
61K
|
14
|
|
ASX - By Stock
|
SLX |
Re:
30th June 2022 Share Price Prediction
|
|
PVPVG
|
92 |
34K |
3 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
92
|
34K
|
3
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
8 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
985
|
404K
|
8
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
6 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
985
|
404K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
|
|
PVPVG
|
27 |
5.8K |
5 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
27
|
5.8K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
|
|
PVPVG
|
27 |
5.8K |
1 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
27
|
5.8K
|
1
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
6 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
985
|
404K
|
6
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
4 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
985
|
404K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
|
|
PVPVG
|
27 |
5.8K |
2 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
27
|
5.8K
|
2
|
|
ASX - By Stock
|
SLX Energy |
Re:
Nuclear Power Related Media Thread
|
|
PVPVG
|
5.0K |
2.1M |
3 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
5.0K
|
2.1M
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Broker Briefing Presentation
|
|
PVPVG
|
23 |
6.5K |
12 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
23
|
6.5K
|
12
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
1 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
985
|
404K
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Agreement to Provide Payment Solutions to RKN Users
|
|
PVPVG
|
77 |
21K |
10 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
77
|
21K
|
10
|
|
ASX - By Stock
|
SLX |
Re:
Ann: IQE Pauses cREO Development
|
|
PVPVG
|
21 |
7.1K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
21
|
7.1K
|
1
|
|
ASX - By Stock
|
SLX |
Re:
Share price
|
|
PVPVG
|
985 |
404K |
6 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
985
|
404K
|
6
|
|
ASX - By Stock
|
RNT Technology |
Re:
Chart Thread
|
|
PVPVG
|
211 |
139K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
211
|
139K
|
2
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
PVPVG
|
4.5K |
1.2M |
4 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
4.5K
|
1.2M
|
4
|
|
ASX - By Stock
|
SLX |
Re:
Ann: IQE Pauses cREO Development
|
|
PVPVG
|
21 |
7.1K |
4 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
21
|
7.1K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Chart - EMD
|
|
PVPVG
|
90 |
26K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
90
|
26K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Chart - EMD
|
|
PVPVG
|
90 |
26K |
8 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
90
|
26K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Broker Briefing Presentation
|
|
PVPVG
|
23 |
6.5K |
7 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
23
|
6.5K
|
7
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Broker Briefing Presentation
|
|
PVPVG
|
23 |
6.5K |
8 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
23
|
6.5K
|
8
|
|
ASX - By Stock
|
RNT Technology |
Re:
Chart Thread
|
|
PVPVG
|
211 |
139K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
211
|
139K
|
0
|
|
ASX - By Stock
|
NOV |
Re:
Bucket list when NOV hits $1
|
|
PVPVG
|
25 |
8.4K |
4 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
25
|
8.4K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria to present webinar, March 24th
|
|
PVPVG
|
1 |
636 |
11 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
1
|
636
|
11
|
|